Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 19 of the 20 references it cites were found in a registry or an index.

Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung

Open access

Abstract

Introduction: SARS-CoV-2 might spread through the nervous system, reaching respiratory centers in the brainstem. Because we recently reported neurophysiological brainstem reflex abnormalities in COVID-19 patients, we here neuropathologically assessed structural brainstem damage in two COVID-19 patients. Materials and methods: We assessed neuropathological features in two patients who died of COVID-19 and in two COVID-19 negative patients as controls. Neuronal damage and corpora amylacea (CA) numbers /mm 2 were histopathologically assessed. Other features studied were the immunohistochemical expression of the SARS-CoV-2 nucleoprotein (NP) and the Iba-1 antigen for glial activation. Results: Autopsies showed normal gross brainstem anatomy. Histopathological examination demonstrated increased neuronal and CA damage in Covid-19 patients’ medulla oblongata. Immunohistochemistry disclosed SARS-CoV-2 NP in brainstem neurons and glial cells, and in cranial nerves. Glial elements also exhibited a widespread increase in Iba-1 expression. Sars-Co-V2 was immunohistochemically detected in the vagus nerve fibers. Discussion: Neuropathologic evidence showing SARS-CoV-2 in the brainstem and medullary damage in the area of respiratory centers strongly suggests that the pathophysiology of COVID-19-related respiratory failure includes a neurogenic component. Sars-Co-V2 detection in the vagus nerve, argues for viral trafficking between brainstem and lung.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00415-021-10604-8

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Macroscopic brainstem appearance in COVID-19-patients. A Anterior surface after major arterial vessel removal: no evidence of pathological changes. Dx: right side. Asterisk: right medulla oblongata (bulb) area removed for tissue sampling. B Transverse brainstem sections. No evidence of gross pathological changes. The solid arrow (top) indicates the section at cerebral peduncle and the substantia nigra levels. The asterisks correspond to the sampled area in image A. The dashed arrow (bottom) corresponds to the most caudal medulla oblongata section. C Left brainstem (dorsal face on the right). C.alPed: cerebellar stalk
Fig. 1 Macroscopic brainstem appearance in COVID-19-patients. A Anterior surface after major arterial vessel removal: no evidence of pathological changes. Dx: right side. Asterisk: right medulla oblongata (bulb) area removed for tissue sampling. B Transverse brainstem sections. No evidence of gross pathological changes. The solid arrow (top) indicates the section at cerebral peduncle and the substantia nigra levels. The asterisks correspond to the sampled area in image A. The dashed arrow (bottom) corresponds to the most caudal medulla oblongata section. C Left brainstem (dorsal face on the right). C.alPed: cerebellar stalkCC BY · PubMed Central
Fig. 2 Microscopic brainstem examination. I. Images are obtained by Nanozoomer Hamamatsu s360 and magnification is represented as scale bare. Histopathological features of nervous tissue damage in the pons and medulla oblongata (MO; scale bare: 50 µm). A–D and F are from COVID-19 patients. A Pons, V motor nucleus. Different types of neuronal damage: neurons with condensed chromatin and shrunken cell body (black arrow), and neuronal chromatolysis (yellow arrows), magnified respectively in the black and yellow insert at the top left. Tissue oedema is absent (haematoxylin & eosin [H&E] staining). B MO, reticular formation: the neurons (some indicated by arrows) are damaged. Tissue oedema is absent (H&E). C MO, reticular formation: axonal damage; the myelin sheaths are detached from the axons and fibers vary in diameter; some corpora amylacea are visible (arrows) in the red insert (magnification of the hatched area; H&E). D MO, reticular formation: myelin sheaths (in dark blue) vary in thickness and size (Klüver-Barrera staining). E Patient unaffected by COVID-19 (control). Pons, reticular formation. The parenchyma appears well preserved and contains a single corpus amylacea (arrow; H&E). F Pons, reticular formation. The parenchyma in this patient with COVID-19 appears characterized by many corpora amylacea (arrows) (H&E). II. Immunohistochemistry. Nucleoprotein (NP) neuronal immunoreactivity (in magenta) in the medulla oblongata (MO) and pons. A MO. A low-power view of NP positive (intracytoplasmic magenta staining) and negative neurons in the motor nucleus of the trigeminal nerve (scale bare: 100 µm). B Magnification of two neurons, one infected by the virus (lower left) and one negative, with basophilic tigroid substance granules; some corpora amylacea are seen (arrows; scale bare: 50 µm). C Red granules show viral NP immunoreactivity in glial elements surrounding neurons in the motor nucleus of the trigeminal nerve (scale bare: 100 µm). D Low magnification of a bulbar section at the level of vagus nerve fibers (scale bare: 500 µm). E and F NP immunoreactivity is visible in nerve fibers entering the brainstem (E, black inset with asterisk; scale bare: 50 µm) and in neurons of the nucleus ambiguous (F, red insert with triangle; scale bare: 100 µm)
Fig. 2 Microscopic brainstem examination. I. Images are obtained by Nanozoomer Hamamatsu s360 and magnification is represented as scale bare. Histopathological features of nervous tissue damage in the pons and medulla oblongata (MO; scale bare: 50 µm). A–D and F are from COVID-19 patients. A Pons, V motor nucleus. Different types of neuronal damage: neurons with condensed chromatin and shrunken cell body (black arrow), and neuronal chromatolysis (yellow arrows), magnified respectively in the black and yellow insert at the top left. Tissue oedema is absent (haematoxylin & eosin [H&E] staining). B MO, reticular formation: the neurons (some indicated by arrows) are damaged. Tissue oedema is absent (H&E). C MO, reticular formation: axonal damage; the myelin sheaths are detached from the axons and fibers vary in diameter; some corpora amylacea are visible (arrows) in the red insert (magnification of the hatched area; H&E). D MO, reticular formation: myelin sheaths (in dark blue) vary in thickness and size (Klüver-Barrera staining). E Patient unaffected by COVID-19 (control). Pons, reticular formation. The parenchyma appears well preserved and contains a single corpus amylacea (arrow; H&E). F Pons, reticular formation. The parenchyma in this patient with COVID-19 appears characterized by many corpora amylacea (arrows) (H&E). II. Immunohistochemistry. Nucleoprotein (NP) neuronal immunoreactivity (in magenta) in the medulla oblongata (MO) and pons. A MO. A low-power view of NP positive (intracytoplasmic magenta staining) and negative neurons in the motor nucleus of the trigeminal nerve (scale bare: 100 µm). B Magnification of two neurons, one infected by the virus (lower left) and one negative, with basophilic tigroid substance granules; some corpora amylacea are seen (arrows; scale bare: 50 µm). C Red granules show viral NP immunoreactivity in glial elements surrounding neurons in the motor nucleus of the trigeminal nerve (scale bare: 100 µm). D Low magnification of a bulbar section at the level of vagus nerve fibers (scale bare: 500 µm). E and F NP immunoreactivity is visible in nerve fibers entering the brainstem (E, black inset with asterisk; scale bare: 50 µm) and in neurons of the nucleus ambiguous (F, red insert with triangle; scale bare: 100 µm)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 87

Metadata

Authors
Bulfamante, G., Bocci, T., Falleni, M., Campiglio, L., Coppola, S., Tosi, D., Chiumello, D., & Priori, A.
Affiliations
University of Milan (IT)
Corresponding author
Priori, Alberto
Venue
Journal of Neurology
Published
2021-05-18
Volume
268
Issue
12
Pages
4486-4491
ISSN
  • 0012-1037 (ISSN-L)
  • 0340-5354
  • 1432-1459
OpenAlex
W3163056168
Cited by
83
References
20
Citations by year
2026: 4 · 2025: 8 · 2024: 16 · 2023: 22 · 2022: 26 · 2021: 7
FWCI
8.49
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Neurology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by)
Funders
Fondazione Romeo ed Enrica Invernizzi (Bando COVID-19)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
COVID-19 pandemic, SARS-CoV-2, medulla oblongata, respiratory center, Iba1, glial activation, vagus nerve, viral trafficking, cranial nerves
MeSH terms
COVID-19, SARS-CoV-2, Brain Stem, Humans, Lung, Nervous System Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung. https://app.cochat.ai/papers/10.1007/s00415-021-10604-8
The paper
Bulfamante, G., Bocci, T., Falleni, M., Campiglio, L., Coppola, S., Tosi, D., Chiumello, D., & Priori, A. (2021). Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung. Journal of Neurology. https://doi.org/10.1007/s00415-021-10604-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.